Table 3.
Comparison | Groups | No. of targets (%) | No. of links (%) |
---|---|---|---|
Normal vs. Adenoma | Common | 132 (15.2%) | 285 (18.1%) |
Differential (varied and stage-specific) | 770 (84.8%) | 1228 (81.9%) | |
Adenoma vs. Carcinoma | Common | 145 (15.7%) | 241 (15.4%) |
Differential (varied and stage-specific) | 781 (84.3%) | 1323 (84.5%) |
“Differential” means targets or links with substantial changes between two stage-specific GRNs; “common” means targets or links with only slight or no changes between two stage-specific GRNs.